Lance Palmer will be facing Alex Gilpin on December 31, 2019 at the Madison Square Garden in New York City. The fight will air at 7 p.m. EST on ESPN 2. Palmer—a former All-American wrestler and current MMA champion in [...]

Doreen Santora, RN, MPH, chief executive officer of Blue Horizon International, will be recognized as a top nurse by the International Nurses Association and will be featured in the publication Worldwide Leaders in Healthcare.  Ms. Santora is receiving this honor [...]

On August 2nd, 2019 IFBB Pro Champion and professional fitness model Anton Antipov hosts the podcast Gee Talks, and recently had Dr. Brian Mehling on as a guest to have a long, wide-ranging discussion about the potential of stem cell science. Antipov [...]

[...]

Lance Palmer is a featherweight MMA champion who credits stem cell treatments from BHI with a greater feeling of better overall health, more energy, and help with the training recovery process. Mr. Palmer is a former amateur wrestler and current mixed [...]

BHI Rejuve, a hormone optimization program, exhibited at the Europa Games Nutrition & Wellness Expo in Dallas on June 8-9, 2019. Attendees of the conference include individuals who are eager to learn more about improving their quality of life. More than [...]

Brian Mehling, MD, and Michael Kelly, MD had a successful presentation at the Princess Grace Hospital Monaco in Monte Carlo, France.  Dr. Brian Mehling’s presentation was focused on BHI Therapeutic Sciences (BHITS) stem cell research studies. It included BHITS stem [...]

Blue Horizon Charitable Foundation was represented at the World Bank and International Monetary Fund Annual Meetings in DC. This year’s events took place in Washington, D.C. from October 14-20, 2019. Katarina Novakova, Events & Guest Relations Manager at Blue Horizon [...]

Clinical trials are research investigations that play an important role in the development of health information and research for public health care. Clinical trials guiding principles are based on maximum benefit and minimal risk to the participants enrolled in a [...]

BHI Therapeutic Sciences (BHITS) has been invited to present its abstract, “A retrospective chart review study of allogeneic umbilical cord blood mononuclear cell therapy for stroke,” at the German Stem Cell Network’s 7th Annual GSCN Conference being held Sept. 23-25 at the Max Delbruck [...]